DeepMed Research

KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTER

🇸🇦Saudi Arabia

Country: 🇸🇦Saudi Arabia

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Optic Nerve Sheath Diameter as a Screening Test for Increased Intracranial Pressure

Conditions: Coma

First Posted Date: 2015-01-14

Last Posted Date: 2015-06-16

Lead Sponsor: King Faisal Specialist Hospital & Research Center

Target Recruit Count: 100

Registration Number: NCT02338284

Locations: 🇸🇦
King Faisal Specialist Hospital & Research Centre, Riyadh, Ar-Riyadh, Saudi Arabia

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)

Phase 4

Completed

Conditions: Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition

Interventions: Drug: Glargine Insulin
Drug: Regular insulin

First Posted Date: 2014-08-15

Last Posted Date: 2016-02-25

Lead Sponsor: King Faisal Specialist Hospital & Research Center

Target Recruit Count: 61

Registration Number: NCT02216799

Locations: 🇸🇦
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial

Not Applicable

Terminated

Conditions: Infant, Very Low Birth Weight

Interventions: Drug: Glycerin suppositories

First Posted Date: 2013-02-27

Last Posted Date: 2024-03-06

Lead Sponsor: King Faisal Specialist Hospital & Research Center

Target Recruit Count: 220

Registration Number: NCT01799629

Locations: 🇸🇦
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
🇸🇦
Sulaiman Al habib Medical Center, Riyadh, Saudi Arabia
🇸🇦
Security Forces Hospital, Riyadh, Saudi Arabia

Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer

Phase 2

Terminated

Conditions: Carcinoma of Esophagus

Interventions: Drug: irinotecan and docetaxel
Drug: Cisplatin, fluorouracil and concurrent radiation therapy

First Posted Date: 2012-05-31

Last Posted Date: 2018-08-10

Lead Sponsor: King Faisal Specialist Hospital & Research Center

Target Recruit Count: 170

Registration Number: NCT01608464

Locations: 🇸🇦
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation

Phase 3

Completed

Conditions: Transplantation for Hematologic Malignancies

Interventions: Procedure: G-PB Transplant
Procedure: G-BM Transplant

First Posted Date: 2012-02-10

Last Posted Date: 2018-08-10

Lead Sponsor: King Faisal Specialist Hospital & Research Center

Target Recruit Count: 230

Registration Number: NCT01530581

Locations: 🇸🇦
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia

Phase 2

Completed

Conditions: Acquired Aplastic Anaemia

Interventions: Drug: Rabbit ATG, Thymoglobuline (Genzyme)

First Posted Date: 2012-02-10

Last Posted Date: 2016-02-25

Lead Sponsor: King Faisal Specialist Hospital & Research Center

Target Recruit Count: 35

Registration Number: NCT01530555

Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Drug: Goserelin (Zoladex)
Drug: Standard cyclophosphamide

First Posted Date: 2012-02-10

Last Posted Date: 2016-02-25

Lead Sponsor: King Faisal Specialist Hospital & Research Center

Target Recruit Count: 416

Registration Number: NCT01530607

Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma

Phase 3

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Bortezomib/Lenalidomide/ Low dose Dex
Drug: Lenalidomide/Low dose Dex
Drug: Lenalidomide

First Posted Date: 2012-02-10

Last Posted Date: 2016-02-25

Lead Sponsor: King Faisal Specialist Hospital & Research Center

Target Recruit Count: 440

Registration Number: NCT01530594

Locations: 🇸🇦
King Faisal Specialist Hospital &Reseach Center, Riyadh, Saudi Arabia

The Placebo Effect May Involve Modulating Drug Bioavailability

Not Applicable

Completed

Conditions: Placebo Effect
Drug Half Life
Pharmacokinetics

Interventions: Drug: Caffeine, paracetamol, cephalexin, or ibuprofen
Drug: Placebo (caffeine, paracetamol, cephalexin, or ibuprofen)

First Posted Date: 2011-12-29

Last Posted Date: 2013-04-09

Lead Sponsor: King Faisal Specialist Hospital & Research Center

Target Recruit Count: 162

Registration Number: NCT01501747

Locations: 🇸🇦
King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size

Not Applicable

Completed

Conditions: Placebo Drug Interaction
Placebo Effect

Interventions: Other: Placebo
Drug: hydroxyzine/placebo
Drug: Hydroxizine

First Posted Date: 2011-12-29

Last Posted Date: 2017-03-03

Lead Sponsor: King Faisal Specialist Hospital & Research Center

Target Recruit Count: 480

Registration Number: NCT01501591

Locations: 🇸🇦
King Faisal Specialist Hospital & research Center, Riyadh, Saudi Arabia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy